(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BODYLOGICMD HORMONE THERAPY INTEGRATIVEMEDICINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BODYLOGICMD HORMONE THERAPY INTEGRATIVEMEDICINE

ST13

US500000087240600

Class

35, 42, 44

Filing

87240600

Registration

5254887

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

08/01/2026

Trademark type

Combined

Nice classes

35, 42, 44

Filing date

11/17/2016

Registration date

08/01/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/07/2024

Last transaction

08/01/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

11/17/2016

First use in commerce

11/17/2016

Drawing code

3

Owner type

03

Owner location

Boca Raton, FL, US

Examiner

FRENCH, CURTIS W

Current location

Historical data usage

Mark description

The mark consists of "BODYLOGICMD" within a dark rectangular background with a design consisting of three overlapping circles within a light square background located to the right of "BODYLOGICMD", and the words "HORMONE THERAPY" followed by a short vertical line followed by the words "INTEGRATIVE MEDICINE", all below "BODYLOGICMD" and said three circle design.

Holders and representatives

Holders

BODYLOGICMD FRANCHISE CORP.

Representatives

Manuel R. Valcarcel Greenberg Traurig, P.A.

Technical classification

Nice Classes

Class 35Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Franchise servicesoffering business management assistance in the establishment and operation of medical offices or clinics providing hormone replacement therapy services

Class 42

Providing a secure electronic online system featuring technology which allows patients to conduct self-evaluationsobtain information and schedule appointments with physicians and other healthcare providers for hormone replacement therapy services

Class 44

Medical servicesproviding hormone replacement therapy services to individuals; providing an interactive virtual medical office computer database in the field of medicine for use by doctorspatients and staff

Publications

History of USPTO decisions and trademark events.

28 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/01/2026

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

09/07/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/07/2024

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

08/20/2024

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

08/19/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/17/2024

E815

TEAS SECTION 8 & 15 RECEIVED

02/01/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/01/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/05/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/05/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

08/01/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/16/2017

PUBO

PUBLISHED FOR OPPOSITION

05/16/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/26/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/03/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

03/09/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/09/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

03/09/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/09/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/28/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/28/2017

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

02/22/2017

GPRA

PRIORITY ACTION E-MAILED

02/22/2017

CPRA

PRIORITY ACTION WRITTEN

02/22/2017

DOCK

ASSIGNED TO EXAMINER

02/15/2017

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/24/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/23/2016

NWAP

NEW APPLICATION ENTERED

11/21/2016

Continuous trademark protection

Get notified about every new filing that threatens BODYLOGICMD HORMONE THERAPY INTEGRATIVEMEDICINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.